Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III open-label randomized study of baloxavir marboxil in Chinese children with influenza
CTR20243000Phase 3Completed
- Sponsor
- Roche
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of baloxavir marboxil in influenza, sponsored by Roche. Started Aug 2024; status: completed.
02
Drugs
baloxavir marboxil
03
Conditions
influenza
Beyond the preview
Go deeper on CTR20243000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243000.